DarioHealth Q3 EPS $(0.49) Misses $(0.46) Estimate, Sales $3.52M Miss $5.34M Estimate
Portfolio Pulse from Benzinga Newsdesk
DarioHealth (NASDAQ:DRIO) reported Q3 losses of $(0.49) per share, missing the analyst consensus estimate of $(0.46) by 6.52%. The company also reported quarterly sales of $3.52 million, missing the analyst consensus estimate of $5.34 million by 34.12%. This represents a 23.44% increase in losses and a 46.74% decrease in sales compared to the same period last year.
November 02, 2023 | 10:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DarioHealth's Q3 earnings missed estimates, with higher losses and lower sales than expected. This could negatively impact the company's stock price in the short term.
DarioHealth's Q3 earnings report shows higher losses and lower sales than expected, which is typically seen as negative by investors and could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100